KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other Non-Current Assets (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Other Non-Current Assets for 18 consecutive years, with $2.1 billion as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 52.87% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $2.1 billion, up 52.87%, while the annual FY2025 figure was $1.8 billion, 60.32% up from the prior year.
  • Other Non-Current Assets hit $2.1 billion in Q1 2026 for Regeneron Pharmaceuticals, up from $1.8 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.1 billion in Q1 2026 and bottomed at $262.0 million in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $881.3 million, with a median of $470.2 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets grew 28.01% in 2023 and then surged 196.28% in 2025.
  • Regeneron Pharmaceuticals' Other Non-Current Assets stood at $336.4 million in 2022, then skyrocketed by 32.02% to $444.1 million in 2023, then skyrocketed by 155.8% to $1.1 billion in 2024, then soared by 60.32% to $1.8 billion in 2025, then grew by 16.94% to $2.1 billion in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2.1 billion, $1.8 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.